PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model - Li, Yuan; Du, Yang; Sun, Ting; Xue, Huadan; Jin, Zhengyu; Tian, Jie (BMC cancer, 2018)
Keywords: Acids; Angiogenesis; Animals; Antibodies, Monoclonal - administration & dosage; Antineoplastic Agents, Immunological - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - pharmacology; Antitumor activity; Bioluminescence; Breast cancer; Cancer therapies; Cancer treatment; Care and treatment; Checkpoint inhibitior; Chemotherapy; Disease Models, Animal; Drug dosages; Female; Flow cytometry; Health aspects; Immune system; Immunoglobulins; Immunomodulation; Immunotherapy; Ligands; Lung cancer; Lymphocytes T; Mammary Neoplasms, Experimental - pathology; Medical prognosis; Metastasis; Mice; Mice, Inbred BALB C; Monoclonal antibodies; PD-1; PD-1 protein; Programmed Cell Death 1 Receptor - antagonists & inhibitors; Prostate cancer; Stem cells; Substance abuse treatment; Therapy; Toxicity; Tumor cells; Tumors; Zoledronic acid; Zoledronic Acid - administration & dosage; United States--US; Zoledronic acid; Therapy; Breast cancer; Checkpoint inhibitior; PD-1